MARC record from Internet Archive

LEADER: 03987cam 2200649Ma 4500
001 ocn646759162
003 OCoLC
005 20200510185645.0
008 081218s2001 caua ob 001 0 eng d
006 m o d
007 cr cn|||||||||
040 $aE7B$beng$epn$cE7B$dOCLCQ$dUBY$dOCLCQ$dOPELS$dOCLCQ$dOCLCF$dOCLCQ$dDEBBG$dD6H$dLEAUB$dSFB
019 $a505068867$a1127147565
020 $a0122608275$q(electronic bk.)
020 $a9780122608278$q(electronic bk.)
020 $a1281742589
020 $a9781281742582
020 $a9786611742584
020 $a6611742581
020 $a0080861229
020 $a9780080861227
035 $a(OCoLC)646759162$z(OCoLC)505068867$z(OCoLC)1127147565
050 4 $aRS189$b.A5827 2001eb
082 04 $a615.1/9$223
245 00 $aAnalytical profiles of drug substances.$nVolume 27 /$cedited by Harry G. Brittain.
260 $aSan Diego :$bAcademic Press,$c℗♭2001.
300 $a1 online resource ([xi], 388 pages) :$billustrations.
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 0 $aAnalytical profiles of drug substances ;$vv. 27
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
520 $aAlthough the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together in one source. The scope of the series has recently been expanded to include profiles of excipient materials.
505 0 $aFront Cover; Analytical Profiles of Drug Substances and Excipients; Copyright Page; Contents; Affiliations of Editors and Contributors; Preface; Chapter 1. Arginine; Chapter 2. Fenoterol Hydrobromide; Chapter 3. Fluconazole; Chapter 4. Flutamide; Chapter 5. Histamine; Chapter 6. Ibuprofen; Chapter 7. Ondansetron Hydrochloride; Chapter 8. Sildenafil Citrate; Chapter 9. Correction: Dorzolamide Hydrochloride; Chapter 10. Correction: Mesalamine; Cumulative Index
546 $aEnglish.
650 0 $aDrugs$xAnalysis.
650 0 $aPharmaceutical chemistry.
650 7 $aDrugs$xAnalysis.$2fast$0(OCoLC)fst00898769
650 7 $aPharmaceutical chemistry.$2fast$0(OCoLC)fst01060115
655 4 $aElectronic books.
700 1 $aBrittain, H. G.
710 2 $aAcademy of Pharmaceutical Sciences.$bPharmaceutical Analysis and Control Section.
776 0 $z0122608275
856 40 $3ebrary$uhttp://site.ebrary.com/id/10244775
856 40 $3ScienceDirect$uhttp://www.sciencedirect.com/science/book/9780122608278
856 4 $uhttp://www.sciencedirect.com/science/bookseries/10756280/27$xVerlag$zURL des Erstvero ffentlichers$3Volltext
856 40 $3ScienceDirect$uhttp://dproxy.library.dc-uoit.ca/login?url=https://www.sciencedirect.com/science/book/9780122608278$zeBook available for Durham College via Elsevier. Click link to access
856 40 $3ScienceDirect$uhttp://dproxy.library.dc-uoit.ca/login?url=https://www.sciencedirect.com/science/bookseries/10756280/27$zeSeries Volume available for Durham College via Elsevier. Click link to access
856 40 $3ScienceDirect$uhttps://ezproxy.aub.edu.lb/login?url=http://www.sciencedirect.com/science/book/9780122608278$zClick for electronic access to e-book.
938 $aebrary$bEBRY$nebr10244775
029 1 $aAU@$b000051452560
029 1 $aCHBIS$b010355953
029 1 $aCHVBK$b329782509
029 1 $aDEBSZ$b405330022
994 $aZ0$bP4A
948 $hHELD BY P4A - 115 OTHER HOLDINGS